Please log in to save bookmarks. Only registered users can save their favorite pages.
Journal Properties
Continued as
RSC Medicinal Chemistry
Language
English
Number of Articles
2,375
Abbreviation
MedChemComm
ISSN
2040-2503
e-ISSN
2040-2511
Main Publisher
Royal Society of Chemistry
Publisher
Royal Society of Chemistry (RSC)
Indian UGC
DOAJ (latest)
Description
MedChemComm is a high-impact, peer-reviewed journal that focuses on cutting-edge research in medicinal chemistry and drug discovery. The journal highlights significant advances in the synthesis, design, and biological evaluation of new therapeutic agents. The journal covers a wide range of topics, including chemical biology, molecular modeling, and structure-activity relationships.
Key areas of interest include the design and synthesis of bioactive molecules, the study of drug-target interactions, and the development of new methodologies for drug discovery. It explores the chemical aspects of biology, including the study of enzymes, proteins, and nucleic acids. It welcomes contributions focusing on natural products, synthetic chemistry, and computational methods. MedChemComm is abstracted and indexed in leading databases, such as Chemical Abstracts Service (CAS), Scopus, and Web of Science, ensuring high visibility and discoverability. It targets researchers in academia, pharmaceutical companies, and other related industries.
Published by the Royal Society of Chemistry, the journal encourages submissions that offer innovative approaches to the treatment of diseases. It is committed to open access and rapid publication of high-quality research.